A money-back deal for cholesterol-lowering PCSK9 inhibitors doesn’t cut costs enough, claims a new analysis from a University of Pittsburgh researcher. The drug’s manufacturer says
International prescription drug donation programs make a difference, explains a new white paper from the Global Alliance for Patient Access. But they could work even
Video explains how pay-for-value arrangements can improve patients’ access to innovative medicine WASHINGTON – Today the Alliance for Patient Access released a new video, “Understanding
Opting for cheaper prescription drugs seems like an obvious way to cut health care costs. The assumption has led health plans to employ utilization management
WASHINGTON – Today, the Alliance for Patient Access made the following statement regarding the Institute for Clinical and Economic Review’s (ICER) final report on the value of
By Stuart Isaacson, MD Most all of us know someone living in a long-term care facility – a friend, a former neighbor, a family member.